Court Strips Teva of Four Patents for MS Drug Copaxone By Sam | January 31, 2017 A federal court invalidated four of Teva’s patents that protect its multiple sclerosis drug Copaxone from generic competition. Source: Drug Industry Daily Posted in Drug Industry Daily